2 completed, 1 terminated. 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 3 | 3 | Completed 2, Terminated 1 |
Follow Mixed Connective Tissue Disease: new trials by email Literature Review of Mixed Connective Tissue Disease trials Research Report on Mixed Connective Tissue Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD Rituximab, Cyclophosphamide - Interstitial Lung Disease, Scleroderma | Phase 2 / Phase 3 | Completed | Royal Brompton & Harefield NHS Foundation Trust | 104 | 2014-11-01 | 2021-10-07 |
| A Clinical Trial for CTD-ILD Treatment N-Acetylcysteine - Interstitial Lung Disease, Connective Tissue Disease | Phase 2 / Phase 3 | Terminated | University of Michigan | 5 | 2011-12-01 | 2017-04-06 |
| Alendronate Osteoporosis Study Alendronate - Glucocorticoid-Associated Osteopenia and Osteoporosis | Phase 2 / Phase 3 | Completed | Boston Children's Hospital | 20 | 2003-03-01 | 2017-04-11 |
Dermatomyositis (3) · Connective Tissue Diseases (2) · Lung Diseases, Interstitial (2) · Polymyositis (2) · Scleroderma, Diffuse (2) · Arthritis, Juvenile (1) · Arthritis, Rheumatoid (1) · Crohn Disease (1) · Lupus Erythematosus, Systemic (1) · Myositis (1) · Osteoporosis (1) · Pulmonary Fibrosis (1) · Sjogren's Syndrome (1) · Vasculitis (1)
Muscular Diseases (3) · Musculoskeletal Diseases (3) · Nervous System Diseases (3) · Neuromuscular Diseases (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Arthritis (2) · Autoimmune Diseases (2) · Immune System Diseases (2) · Joint Diseases (2) · Lung Diseases (2) · Myositis (2) · Respiratory Tract Diseases (2) · Rheumatic Diseases (2) · Scleroderma, Systemic (2)
Acetylcysteine (1) · Alendronate (1) · Cyclophosphamide (1) · Rituximab (1)
Boston Children's Hospital (1) · Royal Brompton & Harefield NHS Foundation Trust (1) · University of Michigan (1)
United Kingdom (1) · United States (1)
Catherine Gordon, MD (1) · Toby M Maher, MD PhD (1)